CSTL

Castle Biosciences, Inc. Common Stock US Stock
$22.91
Open: $23.03 High: $24.07 Low: $22.09 Close: $22.635
Range: 2022-06-27 - 2022-06-28
Volume:97,299
Market: Open
CSTL
Castle Biosciences, Inc. Common Stock 505 S FRIENDSWOOD DRIVE https://www.castlebiosciences.com
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.
  • CEO:
  • Employees: 400
  • Sector:
  • Industry:
Latest Stocks Posts
Card image
Card image
Card image
CSTL News
Latest news about the CSTL